Y-Intercept (HK)’s CONMED CNMD Stock Holding History

Y-Intercept (HK)’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$559K	Buy	+17,064	New	+$614K	0.01%	1283
2026 Q1	–	Sell	-43,424	Closed	-$1.76M	–	1615
2025 Q4	$1.76M	Buy	43,424 +20,135	+86%	+$876K	0.04%	678
2025 Q3	$1.1M	Buy	+23,289	New	+$1.21M	0.03%	940
2024 Q3	–	Sell	-10,105	Closed	-$700K	–	1375
2024 Q2	$700K	Buy	10,105 +1,265	+14%	+$92.3K	0.04%	668
2024 Q1	$708K	Buy	8,840 +3,737	+73%	+$333K	0.05%	537
2023 Q4	$559K	Buy	+5,103	New	+$528K	0.05%	541
2023 Q2	–	Sell	-4,711	Closed	-$489K	–	1329
2023 Q1	$489K	Buy	+4,711	New	+$456K	0.06%	541
2022 Q2	–	Sell	-3,249	Closed	-$483K	–	903
2022 Q1	$483K	Buy	+3,249	New	+$454K	0.11%	277

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Y-Intercept (HK)'s CNMD Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in CONMED (CNMD) in Q2 2026: 17,064 shares worth $559K. The stake represents 0.01% of the portfolio and ranks #1283 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in CNMD as recently as Q4 2025.

Y-Intercept (HK) first reported a position in CNMD in Q1 2022 and has held it in 8 quarters since. The position peaked at $1.76M in Q4 2025. 247 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

Y-Intercept (HK) held 17,064 shares of CONMED worth $559K as of Q2 2026.
CONMED was a new Y-Intercept (HK) position in Q2 2026.
CONMED made up 0.01% of Y-Intercept (HK)'s portfolio in Q2 2026, its #1283 holding.
Y-Intercept (HK) first reported a position in CONMED in Q1 2022 and has held it in 8 quarters since.
Y-Intercept (HK)'s CONMED position peaked at $1.76M in Q4 2025.
247 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.